{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:53:47Z","timestamp":1777348427289,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.rcsop.2021.100054","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T12:34:33Z","timestamp":1628166873000},"page":"100054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Medications causing potential cognitive impairment are common in nursing home dementia units \u2013 A cross-sectional study"],"prefix":"10.1016","volume":"3","author":[{"given":"Jenny Hansen","family":"Kristensson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Zahirovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Londos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Modig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.rcsop.2021.100054_bb0005","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0531-5565(03)00133-5","article-title":"When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly","volume":"38","author":"Turnheim","year":"2003","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.rcsop.2021.100054_bb0010","author":"The National Board of Health and Welfare"},{"issue":"4","key":"10.1016\/j.rcsop.2021.100054_bb0015","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American geriatrics society 2019 updated AGS beers criteria(R) for potentially inappropriate medication use in older adults","volume":"67","author":"By the American Geriatrics Society Beers Criteria Update Expert P","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"10.1016\/j.rcsop.2021.100054_bb0020","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","article-title":"A drug burden index to define the functional burden of medications in older people","volume":"167","author":"Hilmer","year":"2007","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.rcsop.2021.100054_bb0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/11534320-000000000-00000","article-title":"Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis","volume":"30","author":"Olsson","year":"2010","journal-title":"Clin Drug Investig"},{"issue":"9","key":"10.1016\/j.rcsop.2021.100054_bb0030","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jamda.2016.06.011","article-title":"Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review","volume":"17","author":"Morin","year":"2016","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"10.1016\/j.rcsop.2021.100054_bb0035","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/pds.4142","article-title":"Trends in potentially inappropriate medication prescribing to nursing home patients: comparison of three cross-sectional studies","volume":"26","author":"Halvorsen","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.rcsop.2021.100054_bb0040","article-title":"Assessing potentially inappropriate medications in nursing home residents by NORGEP-NH criteria","volume":"7","author":"Halvorsen","year":"2019","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.rcsop.2021.100054_bb0045","author":"Statistics Sweden"},{"issue":"8","key":"10.1016\/j.rcsop.2021.100054_bb0050","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jamda.2016.03.017","article-title":"Prevalence of dementia with Lewy body symptoms: a cross-sectional study in 40 Swedish nursing homes","volume":"17","author":"Zahirovic","year":"2016","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"10.1016\/j.rcsop.2021.100054_bb0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12877-018-0740-4","article-title":"Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies: a cross-sectional study in 40 nursing homes in Sweden","volume":"18","author":"Zahirovic","year":"2018","journal-title":"BMC Geriatr"},{"issue":"5","key":"10.1016\/j.rcsop.2021.100054_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028010","article-title":"Survival among the older adults with clinical signs of Lewy body dementia in 40 Swedish nursing homes: a 6-year follow-up study","volume":"9","author":"Zahirovic","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.rcsop.2021.100054_bb0070","series-title":"Clinical Pharmacist, Region Sk\u00e5ne","author":"Rube","year":"2021"},{"issue":"8","key":"10.1016\/j.rcsop.2021.100054_bb0075","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","article-title":"Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study","volume":"59","author":"Fox","year":"2011","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.rcsop.2021.100054_bb0080","first-page":"207","article-title":"Over-prescribed medications, under-appreciated risks: a review of the cognitive effects of anticholinergic medications in older adults","volume":"113","author":"Britt","year":"2016","journal-title":"Mo Med"},{"issue":"2","key":"10.1016\/j.rcsop.2021.100054_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2012-110935","article-title":"Anticholinergic drugs in late life: adverse effects on cognition but not on progress to dementia","volume":"30","author":"Whalley","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.rcsop.2021.100054_bb0090","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/ageing\/afu096","article-title":"Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review","volume":"43","author":"Fox","year":"2014","journal-title":"Age Ageing"},{"key":"10.1016\/j.rcsop.2021.100054_bb0095","doi-asserted-by":"crossref","first-page":"k1315","DOI":"10.1136\/bmj.k1315","article-title":"Anticholinergic drugs and risk of dementia: case-control study","volume":"361","author":"Richardson","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.rcsop.2021.100054_bb0100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.rcsop.2021.100054_bb0105","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12877-019-1280-2","article-title":"Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study","volume":"19","author":"Grossi","year":"2019","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.rcsop.2021.100054_bb0110","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3389\/fnins.2019.01309","article-title":"Anticholinergic drugs in geriatric psychopharmacology","volume":"13","author":"Lopez-Alvarez","year":"2019","journal-title":"Front Neurosci"},{"issue":"9247","key":"10.1016\/j.rcsop.2021.100054_bb0115","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study","volume":"356","author":"McKeith","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rcsop.2021.100054_bb0120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12877-018-0929-6","article-title":"An anticholinergic burden score for German prescribers: score development","volume":"18","author":"Kiesel","year":"2018","journal-title":"BMC Geriatr"},{"issue":"4","key":"10.1016\/j.rcsop.2021.100054_bb0125","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/jgs.12730","article-title":"Detroit expert panel on a, Management of Neuropsychiatric Symptoms of D. Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel","volume":"62","author":"Kales","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"suppl 2","key":"10.1016\/j.rcsop.2021.100054_bb0130","first-page":"5","article-title":"Expert consensus panel for using antipsychotic drugs in older P. using antipsychotic agents in older patients","volume":"65","author":"Alexopoulos","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.rcsop.2021.100054_bb0135","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nrn1926","article-title":"Neuroleptic drugs in dementia: benefits and harm","volume":"7","author":"Ballard","year":"2006","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.rcsop.2021.100054_bb0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1017\/S1041610212001627","article-title":"Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review","volume":"25","author":"Seitz","year":"2013","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.rcsop.2021.100054_bb0145","first-page":"1363","article-title":"Use of atypical antipsychotics in the elderly: a clinical review","volume":"9","author":"Gareri","year":"2014","journal-title":"Clin Interv Aging"},{"issue":"8","key":"10.1016\/j.rcsop.2021.100054_bb0150","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2165\/00002512-200825080-00005","article-title":"Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study","volume":"25","author":"Hosia-Randell","year":"2008","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.rcsop.2021.100054_bb0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12877-017-0608-z","article-title":"Potentially inappropriate medication use in nursing homes: an observational study using the NORGEP-NH criteria","volume":"17","author":"Nyborg","year":"2017","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.rcsop.2021.100054_bb0160","doi-asserted-by":"crossref","first-page":"w20126","DOI":"10.4414\/smw.2019.20126","article-title":"Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data","volume":"149","author":"Schneider","year":"2019","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"10.1016\/j.rcsop.2021.100054_bb0165","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2174\/1574884710666150609154741","article-title":"Inappropriate drug use in people with cognitive impairment and dementia: a systematic review","volume":"10","author":"Johnell","year":"2015","journal-title":"Curr Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.rcsop.2021.100054_bb0170","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1017\/S1041610218001229","article-title":"Prescribing of psychotropic drugs and indicators for use in residential aged care and residents with dementia","volume":"31","author":"Brimelow","year":"2019","journal-title":"Int Psychogeriatr"},{"issue":"11","key":"10.1016\/j.rcsop.2021.100054_bb0175","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.mayocp.2016.07.024","article-title":"Benzodiazepine use in older adults: dangers, management, and alternative therapies","volume":"91","author":"Markota","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rcsop.2021.100054_bb0180","author":"The National Board of Health and Welfare"},{"key":"10.1016\/j.rcsop.2021.100054_bb0185","series-title":"Pharmacist, Region Sk\u00e5ne","author":"Lenander","year":"2021"},{"issue":"1","key":"10.1016\/j.rcsop.2021.100054_bb0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/pm\/pnx268","article-title":"Opioid prescription use in nursing home residents with advanced dementia","volume":"20","author":"Griffioen","year":"2019","journal-title":"Pain Med"},{"issue":"4","key":"10.1016\/j.rcsop.2021.100054_bb0195","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/jgs.16293","article-title":"Pain patterns and treatment among nursing home residents with moderate-severe cognitive impairment","volume":"68","author":"Ersek","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10.1016\/j.rcsop.2021.100054_bb0200","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jalz.2014.06.013","article-title":"Frequent use of opioids in patients with dementia and nursing home residents: a study of the entire elderly population of Denmark","volume":"11","author":"Jensen-Dahm","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.rcsop.2021.100054_bb0205","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12888-017-1409-9","article-title":"Trends in treatment with antipsychotic medication in relation to national directives, in people with dementia - a review of the Swedish context","volume":"17","author":"Karlsson","year":"2017","journal-title":"BMC Psychiatry"},{"issue":"9","key":"10.1016\/j.rcsop.2021.100054_bb0210","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1080\/13607863.2017.1348469","article-title":"Psychotropic drug prescription for nursing home residents with dementia: prevalence and associations with non-resident-related factors","volume":"22","author":"Smeets","year":"2018","journal-title":"Aging Ment Health"},{"issue":"3","key":"10.1016\/j.rcsop.2021.100054_bb0215","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40801-017-0111-z","article-title":"Use of antipsychotic drugs by elderly primary care patients and the effects of medication reviews: a cross-sectional study in Sweden","volume":"4","author":"Lenander","year":"2017","journal-title":"Drugs Real World Outcomes"},{"issue":"4","key":"10.1016\/j.rcsop.2021.100054_bb0220","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jamda.2008.11.005","article-title":"A preliminary study of anticholinergic burden and relationship to a quality of life indicator, engagement in activities, in nursing home residents with dementia","volume":"10","author":"Kolanowski","year":"2009","journal-title":"J Am Med Dir Assoc"},{"issue":"12","key":"10.1016\/j.rcsop.2021.100054_bb0225","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2165\/11584430-000000000-00000","article-title":"Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey","volume":"27","author":"Chatterjee","year":"2010","journal-title":"Drugs Aging"},{"issue":"10","key":"10.1016\/j.rcsop.2021.100054_bb0230","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/gerona\/gly078","article-title":"The impact of dementia diagnosis on patterns of potentially inappropriate medication use among older adults","volume":"73","author":"Gnjidic","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"10.1016\/j.rcsop.2021.100054_bb0235","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/gps.4844","article-title":"Measuring anticholinergic exposure in patients with dementia: a comparative study of nine anticholinergic risk scales","volume":"33","author":"Turro-Garriga","year":"2018","journal-title":"Int J Geriatr Psychiatry."},{"issue":"10","key":"10.1016\/j.rcsop.2021.100054_bb0240","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/gps.5160","article-title":"Potentially inappropriate prescribing in people with dementia: an Australian population-based study","volume":"34","author":"Eshetie","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.rcsop.2021.100054_bb0245","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40266-019-00720-6","article-title":"Temporal trends in the use of anticholinergic drugs among older people living in long-term care facilities in Helsinki","volume":"37","author":"Aalto","year":"2020","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.rcsop.2021.100054_bb0250","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/gerona\/gls176","article-title":"Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial","volume":"68","author":"Kersten","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"10.1016\/j.rcsop.2021.100054_bb0255","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jagp.2017.08.005","article-title":"Reduction of the anticholinergic burden makes it possible to decrease behavioral and psychological symptoms of dementia","volume":"26","author":"Jaidi","year":"2018","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.rcsop.2021.100054_bb0260","series-title":"Koncernkontoret. Avd f\u00f6r h\u00e4lso- och sjukv\u00e5rdsstyrning. L\u00e4kemedelsr\u00e5det och Omr\u00e5de l\u00e4kemedel. Tolkningsdokument: HSLF-FS 2017:37 och framtagna modeller inom Region Sk\u00e5ne","author":"Interpretation Document for Consitution","year":"2019"},{"issue":"4","key":"10.1016\/j.rcsop.2021.100054_bb0265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40266-013-0057-0","article-title":"Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study","volume":"30","author":"Milos","year":"2013","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.rcsop.2021.100054_bb0270","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40266-017-0513-3","article-title":"Associations between the drug burden index, potentially inappropriate medications and quality of life in residential aged care","volume":"35","author":"Harrison","year":"2018","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.rcsop.2021.100054_bb0275","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jamda.2015.12.011","article-title":"Burden of potentially harmful medications and the association with quality of life and mortality among institutionalized older people","volume":"17","author":"Juola","year":"2016","journal-title":"J Am Med Dir Assoc"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276621000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276621000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:27:34Z","timestamp":1757406454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276621000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":54,"alternative-id":["S2667276621000548"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2021.100054","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medications causing potential cognitive impairment are common in nursing home dementia units \u2013 A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2021.100054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100054"}}